#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function


Calmodulin (CaM) is a highly abundant, ubiquitous, small protein, which plays a major role in the transmission of calcium signals to target proteins in eukaryotes. Hundreds of CaM targets are known, and their respective cellular functions include signaling, metabolism, cytoskeletal regulation, and ion channel regulation, to name but a few. CaM is frequently modified after translation, including frequently trimethylation at a single amino acid, however, the role of this methylation is not known. Human patients with a homozygous deletion of the gene that methylates CaM, CaM-KMT, are known, but they also have a deletion of additional genes. Thus, to study the role of CaM–KMT, we produced a mouse model in which CaM-KMT is the only deleted gene, with the deletion constructed as in the human patients. The model proved to reveal the function of methylation of CaM, since CaM was found to be non-methylated and the methylation of CaM found to be important in growth, muscle strength, somatosensory development and brain function. The current study also has clinical implications for human patients. Patients presenting slow growth and muscle weakness that could result from a mitochondrial impairment and mental retardation should be considered for sequence analysis of the CaM KMT gene.


Vyšlo v časopise: Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function. PLoS Genet 11(8): e32767. doi:10.1371/journal.pgen.1005388
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1005388

Souhrn

Calmodulin (CaM) is a highly abundant, ubiquitous, small protein, which plays a major role in the transmission of calcium signals to target proteins in eukaryotes. Hundreds of CaM targets are known, and their respective cellular functions include signaling, metabolism, cytoskeletal regulation, and ion channel regulation, to name but a few. CaM is frequently modified after translation, including frequently trimethylation at a single amino acid, however, the role of this methylation is not known. Human patients with a homozygous deletion of the gene that methylates CaM, CaM-KMT, are known, but they also have a deletion of additional genes. Thus, to study the role of CaM–KMT, we produced a mouse model in which CaM-KMT is the only deleted gene, with the deletion constructed as in the human patients. The model proved to reveal the function of methylation of CaM, since CaM was found to be non-methylated and the methylation of CaM found to be important in growth, muscle strength, somatosensory development and brain function. The current study also has clinical implications for human patients. Patients presenting slow growth and muscle weakness that could result from a mitochondrial impairment and mental retardation should be considered for sequence analysis of the CaM KMT gene.


Zdroje

1. Kursula P (2014) The many structural faces of calmodulin: a multitasking molecular jackknife. Amino Acids 46: 2295–2304. doi: 10.1007/s00726-014-1795-y 25005783

2. Oh SH, Roberts DM (1990) Analysis of the state of posttranslational calmodulin methylation in developing pea plants. Plant Physiol 93: 880–887. 16667596

3. Takemori N, Komori N, Thompson JN Jr., Yamamoto MT, Matsumoto H (2007) Novel eye-specific calmodulin methylation characterized by protein mapping in Drosophila melanogaster. Proteomics 7: 2651–2658. 17610210

4. Banerjee J, Magnani R, Nair M, Dirk LM, DeBolt S, et al. (2013) Calmodulin-mediated signal transduction pathways in Arabidopsis are fine-tuned by methylation. Plant Cell 25: 4493–4511. doi: 10.1105/tpc.113.119115 24285794

5. Roberts DM, Burgess WH, Watterson DM (1984) Comparison of the NAD Kinase and Myosin Light Chain Kinase Activator Properties of Vertebrate, Higher Plant, and Algal Calmodulins. Plant Physiol 75: 796–798. 16663706

6. Roberts DM, Besl L, Oh SH, Masterson RV, Schell J, et al. (1992) Expression of a calmodulin methylation mutant affects the growth and development of transgenic tobacco plants. Proc Natl Acad Sci U S A 89: 8394–8398. 1325656

7. Magnani R, Dirk LM, Trievel RC, Houtz RL (2010) Calmodulin methyltransferase is an evolutionarily conserved enzyme that trimethylates Lys-115 in calmodulin. Nat Commun 1: 43. doi: 10.1038/ncomms1044 20975703

8. Parvari R, Brodyansky I, Elpeleg O, Moses S, Landau D, et al. (2001) A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease. Am J Hum Genet 69: 869–875. 11524703

9. Parvari R, Gonen Y, Alshafee I, Buriakovsky S, Regev K, et al. (2005) The 2p21 deletion syndrome: characterization of the transcription content. Genomics 86: 195–211. 15913950

10. Szeltner Z, Alshafee I, Juhasz T, Parvari R, Polgar L (2005) The PREPL A protein, a new member of the prolyl oligopeptidase family, lacking catalytic activity. Cell Mol Life Sci 62: 2376–2381. 16143824

11. Magen S, Magnani R, Haziza S, Hershkovitz E, Houtz R, et al. (2012) Human calmodulin methyltransferase: expression, activity on calmodulin, and Hsp90 dependence. PLoS One 7: e52425. doi: 10.1371/journal.pone.0052425 23285036

12. Parvari R, Hershkovitz E (2007) Chromosomal microdeletions and genes' functions: a cluster of chromosomal microdeletions and the deleted genes' functions. Eur J Hum Genet 15: 997–998. 17625506

13. Jaeken J, Martens K, Francois I, Eyskens F, Lecointre C, et al. (2006) Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome. Am J Hum Genet 78: 38–51. 16385448

14. Martens K, Derua R, Meulemans S, Waelkens E, Jaeken J, et al. (2006) PREPL: a putative novel oligopeptidase propelled into the limelight. Biol Chem 387: 879–883. 16913837

15. Eggermann T, Spengler S, Venghaus A, Denecke B, Zerres K, et al. (2012) 2p21 Deletions in hypotonia-cystinuria syndrome. Eur J Med Genet 55: 561–563. doi: 10.1016/j.ejmg.2012.06.008 22766003

16. Regal L, Aydin HI, Dieltjens AM, Van Esch H, Francois I, et al. (2012) Two novel deletions in hypotonia-cystinuria syndrome. Mol Genet Metab 107: 614–616. doi: 10.1016/j.ymgme.2012.06.011 22796000

17. Chabrol B, Martens K, Meulemans S, Cano A, Jaeken J, et al. (2008) Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome. J Med Genet 45: 314–318. doi: 10.1136/jmg.2007.055475 18234729

18. Bartholdi D, Asadollahi R, Oneda B, Schmitt-Mechelke T, Tonella P, et al. (2013) Further delineation of genotype-phenotype correlation in homozygous 2p21 deletion syndromes: first description of patients without cystinuria. Am J Med Genet A 161a: 1853–1859. doi: 10.1002/ajmg.a.35994 23794250

19. Lone AM, Leidl M, McFedries AK, Horner JW, Creemers J, et al. (2014) Deletion of PREPl causes growth impairment and hypotonia in mice. PLoS One 9: e89160. doi: 10.1371/journal.pone.0089160 24586561

20. SJaRD W. (2001) Molecular Cloning A Laboratory Manual. New York: Cold spring harbor laboratory press.

21. Ito M (2000) Mechanisms of motor learning in the cerebellum. Brain Res 886: 237–245. 11119699

22. Jorntell H, Hansel C (2006) Synaptic memories upside down: bidirectional plasticity at cerebellar parallel fiber-Purkinje cell synapses. Neuron 52: 227–238. 17046686

23. Joyce PI, McGoldrick P, Saccon RA, Weber W, Fratta P, et al. (2014) A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity. Hum Mol Genet.

24. Goosens KA (2011) Hippocampal regulation of aversive memories. Curr Opin Neurobiol 21: 460–466. doi: 10.1016/j.conb.2011.04.003 21546244

25. McHugh SB, Deacon RM, Rawlins JN, Bannerman DM (2004) Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety. Behav Neurosci 118: 63–78. 14979783

26. Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106: 274–285. 1590953

27. Rowe PM, Wright LS, Siegel FL (1986) Calmodulin N-methyltransferase. Partial purification and characterization. J Biol Chem 261: 7060–7069. 3700427

28. Yazawa M, Kuwayama H, Yagi K (1978) Modulator protein as a Ca2+-dependent activator of rabbit skeletal myosin light-chain kinase. Purification and characterization. J Biochem 84: 1253–1258. 730753

29. Murtaugh TJ, Wright LS, Siegel FL (1986) Posttranslational modification of calmodulin in rat brain and pituitary. J Neurochem 47: 164–172. 3711896

30. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, et al. (2001) A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73: 56–65. 11352566

31. Moore S, Stein WH (1948) Photometric ninhydrin method for use in the chromatography of amino acids. J Biol Chem 176: 367–388. 18886175

32. Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, et al. (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228: 35–51. 7955428

33. Shufaro Y, Lebovich M, Aizenman E, Miller C, Simon A, et al. (2012) Human granulosa luteal cell oxidative phosphorylation function is not affected by age or ovarian response. Fertil Steril 98: 166–172. doi: 10.1016/j.fertnstert.2012.03.051 22578535

34. Golan HM, Lev V, Hallak M, Sorokin Y, Huleihel M (2005) Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 48: 903–917. 15829260

35. Kezurer N, Galron D, Golan HM (2013) Increased susceptibility to mild neonatal stress in MTHFR deficient mice. Behav Brain Res 253: 240–252. doi: 10.1016/j.bbr.2013.07.037 23896051

36. Golan H, Kashtuzki I, Hallak M, Sorokin Y, Huleihel M (2004) Maternal hypoxia during pregnancy induces fetal neurodevelopmental brain damage: partial protection by magnesium sulfate. J Neurosci Res 78: 430–441. 15389830

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2015 Číslo 8
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#